📊 AGL Key Takeaways
Is agilon health, inc. (AGL) a Good Investment?
Agilon Health faces severe operational distress with persistent negative profitability and deteriorating cash flows, burning $119M in free cash flow annually while revenues declined 2.1% YoY. The company's negative net margin of -6.6% and negative operating income of $463.2M indicate fundamental business model challenges that are not self-correcting. With only $173.7M in cash against $1.1B in liabilities and negative interest coverage, the company faces material solvency concerns in the near term.
agilon health’s fundamentals are weak: revenue declined, operating losses remain large, and the business is consuming cash rather than generating it. While debt is low and cash provides some near-term cushion, the combination of negative margins, negative free cash flow, and a very thin equity base points to poor financial quality and elevated balance-sheet risk if losses persist.
Why Buy agilon health, inc. Stock? AGL Key Strengths
- Positive debt-to-equity ratio of 0.28x suggests manageable leverage levels relative to equity base
- Current ratio of 1.02x indicates ability to meet short-term obligations, though tightened
- Maintains $173.7M cash position providing liquidity runway despite operational losses
- Revenue scale remains substantial at $5.93B, which suggests the company still has meaningful market presence
- Debt levels are modest relative to equity, with only $34.99M of long-term debt and a 0.28x debt-to-equity ratio
- Cash of $173.71M and a current ratio of 1.02x provide limited near-term liquidity support
AGL Stock Risks: agilon health, inc. Investment Risks
- Negative free cash flow of -$119M annually is unsustainable and depleting cash reserves at alarming rate
- Operating losses of -$463.2M and negative operating margin of -7.8% indicate inability to generate profit from core operations
- Revenue decline of 2.1% YoY combined with negative profitability suggests deteriorating competitive position in health services sector
- Negative interest coverage of -360.8x indicates company cannot service debt from operating earnings
- Equity base of only $126.7M against $1.3B in assets creates minimal equity cushion for creditors
- Profitability is deeply negative, with a -7.8% operating margin and -6.6% net margin
- Cash generation is weak, with negative operating cash flow and negative free cash flow indicating the model is not self-funding
- Balance-sheet resilience is thin, with only $126.73M of equity and extremely poor ROE/ROA signaling sustained value erosion
Key Metrics to Watch
- Operating cash flow trend - must return to positive to avoid insolvency within 18-24 months
- Revenue stabilization - reversal of YoY decline is prerequisite for recovery
- Operating margin improvement - needs to demonstrate clear path to profitability or break-even operations
- Cash burn rate and remaining cash runway - critical for determining survival timeline
- Operating cash flow and free cash flow trend
- Operating margin improvement versus revenue growth
agilon health, inc. (AGL) Financial Metrics & Key Ratios
💡 AI Analyst Insight
agilon health, inc. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
AGL Profit Margin, ROE & Profitability Analysis
AGL vs Services Sector: How agilon health, inc. Compares
How agilon health, inc. compares to Services sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is agilon health, inc. Stock Overvalued? AGL Valuation Analysis 2026
Based on fundamental analysis, agilon health, inc. has mixed fundamental signals relative to the Services sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
agilon health, inc. Balance Sheet: AGL Debt, Cash & Liquidity
AGL Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: agilon health, inc.'s revenue has grown significantly by 231% over the 5-year period, indicating strong business expansion. The most recent EPS of $-0.48 indicates the company is currently unprofitable.
AGL Revenue Growth, EPS Growth & YoY Performance
AGL Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $1.4B | -$110.2M | $-0.27 |
| Q2 2025 | $1.4B | -$30.7M | $-0.07 |
| Q1 2025 | $1.5B | -$6.1M | $0.00 |
| Q3 2024 | $1.1B | -$31.4M | $-0.06 |
| Q2 2024 | $1.1B | -$727.0K | $-0.01 |
| Q1 2024 | $1.1B | -$6.1M | $0.01 |
| Q3 2023 | $694.9M | -$30.7M | $-0.07 |
| Q2 2023 | $670.1M | -$727.0K | $0.00 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
agilon health, inc. Dividends, Buybacks & Capital Allocation
AGL SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for agilon health, inc. (CIK: 0001831097)
📋 Recent SEC Filings
| Date | Form | Document | Action |
|---|---|---|---|
| Apr 3, 2026 | 4 | xslF345X06/wk-form4_1775259626.xml | View → |
| Apr 3, 2026 | 4 | xslF345X06/wk-form4_1775259553.xml | View → |
| Apr 3, 2026 | 4 | xslF345X06/wk-form4_1775259503.xml | View → |
| Apr 3, 2026 | 4 | xslF345X06/wk-form4_1775259453.xml | View → |
| Apr 3, 2026 | 4 | xslF345X06/wk-form4_1775259395.xml | View → |
❓ Frequently Asked Questions about AGL
What is the AI rating for AGL?
agilon health, inc. (AGL) has a Combined AI Rating of STRONG SELL from Claude (STRONG SELL) and ChatGPT (STRONG SELL) with 92% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are AGL's key strengths?
Claude: Positive debt-to-equity ratio of 0.28x suggests manageable leverage levels relative to equity base. Current ratio of 1.02x indicates ability to meet short-term obligations, though tightened. ChatGPT: Revenue scale remains substantial at $5.93B, which suggests the company still has meaningful market presence. Debt levels are modest relative to equity, with only $34.99M of long-term debt and a 0.28x debt-to-equity ratio.
What are the risks of investing in AGL?
Claude: Negative free cash flow of -$119M annually is unsustainable and depleting cash reserves at alarming rate. Operating losses of -$463.2M and negative operating margin of -7.8% indicate inability to generate profit from core operations. ChatGPT: Profitability is deeply negative, with a -7.8% operating margin and -6.6% net margin. Cash generation is weak, with negative operating cash flow and negative free cash flow indicating the model is not self-funding.
What is AGL's revenue and growth?
agilon health, inc. reported revenue of $5.9B.
Does AGL pay dividends?
agilon health, inc. does not currently pay dividends.
Where can I find AGL SEC filings?
Official SEC filings for agilon health, inc. (CIK: 0001831097) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is AGL's EPS?
agilon health, inc. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is AGL a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, agilon health, inc. has a STRONG SELL rating with 92% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is AGL stock overvalued or undervalued?
Valuation metrics for AGL: ROE of -308.8% (sector avg: 16%), net margin of -6.6% (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
Should I buy AGL stock in 2026?
Our dual AI analysis gives agilon health, inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is AGL's free cash flow?
agilon health, inc.'s operating cash flow is $-105.8M, with capital expenditures of $13.2M. FCF margin is -2.0%.
How does AGL compare to other Services stocks?
Vs Services sector averages: Net margin -6.6% (avg: 10%), ROE -308.8% (avg: 16%), current ratio 1.02 (avg: 1.5).